Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Advanced drug delivery reviews ; h5-index 102.0

Growing evidence suggests that T cells may play a critical role in combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, COVID-19 vaccines that can elicit a robust T cell response may be particularly important. The design, development and experimental evaluation of such vaccines is aided by an understanding of the landscape of T cell epitopes of SARS-CoV-2, which is largely unknown. Due to the challenges of identifying epitopes experimentally, many studies have proposed the use of in silico methods. Here, we present a review of the in silico methods that have been used for the prediction of SARS-CoV-2 T cell epitopes. These methods employ a diverse set of technical approaches, often rooted in machine learning. A performance comparison is provided based on the ability to identify a specific set of immunogenic epitopes that have been determined experimentally to be targeted by T cells in convalescent COVID-19 patients, shedding light on the relative performance merits of the different approaches adopted by the in silico studies. The review also puts forward perspectives for future research directions.

Sohail Muhammad Saqib, Ahmed Syed Faraz, Quadeer Ahmed Abdul, McKay Matthew R


COVID-19, SARS-CoV, allergenicity, computational prediction, coronavirus, immunogenicity, immunoinformatics, peptide-HLA binding, reverse vaccinology, toxicity